検索結果

Management Policy | About Senju | SENJU Pharmaceutical

;Sen-sen" is our mascot embodying the image of Senju Sense. Its name was created by taking the first syllable of each word in "Senju Sense."

产品开发方针 | 研究与开发 | 千寿制药株式会社

而其中10亿人以上未得到必要的治疗。并且报告中还提到白内障、屈光不正（近视、老花眼等）、老年性黄斑变性、青光眼、糖尿病性视网膜病变等是导致全球性视力受损或失明的主要原因。 为创造针对眼部疾病的高价值（First in Class、Best in Class、提升患者便利性等）的产品，今后，我们也将全力推进研究开发活动。我们从“对导致视力受损或失明的眼部疾病的贡献”、“满足未满足的医疗需求*”、“商...

stionnaire, the Dry Eye-Related Quality-of-Life Score (DEQS)*3 . This achievement marks the world’s first successful clinical development of a TRPV1 antagonist for DED, completed in Japan. DED, the ta...

stionnaire, the Dry Eye-Related Quality-of-Life Score (DEQS)*3 . This achievement marks the world’s first successful clinical development of a TRPV1 antagonist for DED, completed in Japan. DED, the ta...

Product Development Policy | Research & Development | SENJU Pharmaceutica

and development activities with the utmost effort to create high-value products for eye diseases (“First in Class”, “Best in Class”, and with enhanced convenience for patients). We mainly identify &q...